Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cequa in Dry Eye Syndrome
NCT04515329Phase 4Withdrawn
- Sponsor
- Vishal Jhanji
- Start
- Dec 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine ophthalmic solution in dry eye syndrome (DED), sponsored by Vishal Jhanji. Planned start Dec 2023; status: withdrawn.
02
Drugs
cyclosporine ophthalmic solution
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT04515329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04515329.